21 June 2022 | News
Companies collaborate to promote the development of bioanalytical skills to enhance regional scientific competitiveness and the quality of pharmaceutical research and testing
Photo Credit: Freepik
Waters Corporation has announced a collaboration with BioInfra, a pioneering contract research organization (CRO) company for the pharmaceutical and clinical fields, to jointly establish the ASEAN Academy for Bioanalysis. The academy is dedicated to providing scientists with the hands-on knowledge required to design and perform a variety of bioanalytical methods, which are vital throughout every stage of drug discovery and development.
David Curtin, Waters Vice President of Asia Pacific said, “Our vision is that the training provided at the ASEAN Academy will help grow generic drug manufacturing in the region, and in turn, help provides lower-cost prescription drug options for the people of Southeast Asia.”
Located at the BioInfra headquarters in Seoul, the ASEAN Academy for Bioanalysis will offer hands-on training using the latest analytical instruments and software from Waters. Trainees will focus on the bioanalytical aspect of bioequivalence trials to ensure they are conducted according to the applicable principles of Good Laboratory Practice (GLP).
Bioanalytical methods used today require samples to be well-characterized, fully validated, and documented to yield reliable results that can be satisfactorily interpreted. These skills will help enhance the regional scientific competitiveness and the quality of pharmaceutical research and testing needed to meet the region’s growing demands for access to clinical trials and generic drugs, which are fueled by rising elderly populations facing acute and chronic illnesses.
Portfolio Management and Pi…
Australia conducts new rese…
Is Singapore ready to becom…
Laboratories in times of so…
“The concept of anti-ageing should,
For the automation portfolio, we se
Is Singapore ready to become a glob
India develops AI tool to detect CO
China focuses on next-generation in
BioNTech to establish first South E
WHO lists China's Sinopharm COVID-1
Taiwan shares 150 oxygen concentrat
Are incubators igniting bioscience ecosystem in Asia?
1 North Bridge Road,
#08-08 High Street Centre,
Email : firstname.lastname@example.org
Visit Our Digital Magazine :
© 2022 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer
Web Interface Conceived and Powered By : SCI Knowledge Interlinks